Back
Perspective Therapeutics Stock Predictions
Sponsored
CATX
Sponsored
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Buy
81
CATX
Perspective Therapeutics
Last Price:
1.81
Seasonality Move:
1.64%
7 Day Trial
ALL ACCESS PASS
$
7
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to SeePerspective Therapeutics Stock Forecast
-
Is Perspective Therapeutics Stock Undervalued?
The current Perspective Therapeutics [CATX] share price is $1.73. The Score for CATX is 81, which is 62% above its historic median score of 50, and infers lower risk than normal. - CATX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
Will Perspective Therapeutics Stock Go Up Next Year?
Data Unavailable
Perspective Therapeutics Stock Rating
Data Unavailable
Perspective Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com
52-Week Data
52-Week High:
1.87
52-Week Low:
0.21
Prediction Charts
Market Cap:
1.02B
Price in USD:
1.73
Volume:
6.88M
Beta:
1.38
Technical Analysis
SMA50:
1.30
SMA100:
0.94
SMA200:
0.64
52-Wk Change:
179.03%
Stock Predictions
-
Is Perspective Therapeutics stock public?
Yes, Perspective Therapeutics is a publicly traded company. -
What is the Perspective Therapeutics stock quote today?
The Perspective Therapeutics stock price is 1.73 USD today. -
How to buy Perspective Therapeutics stock online?
You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-15 | 1.47 | 1.53 | 1.55 | 1.42 |
Apr-16 | 1.51 | 1.46 | 1.54 | 1.40 |
Apr-17 | 1.46 | 1.43 | 1.48 | 1.41 |
Apr-18 | 1.45 | 1.47 | 1.47 | 1.33 |
Apr-19 | 1.44 | 1.50 | 1.50 | 1.36 |
Apr-22 | 1.50 | 1.53 | 1.56 | 1.50 |
Apr-23 | 1.54 | 1.70 | 1.70 | 1.53 |
Apr-24 | 1.67 | 1.69 | 1.77 | 1.65 |
Apr-25 | 1.65 | 1.60 | 1.65 | 1.56 |
Apr-26 | 1.58 | 1.58 | 1.62 | 1.53 |
Apr-29 | 1.59 | 1.64 | 1.70 | 1.59 |
Apr-30 | 1.67 | 1.68 | 1.71 | 1.60 |
May-1 | 1.68 | 1.70 | 1.75 | 1.65 |
May-2 | 1.76 | 1.73 | 1.87 | 1.71 |
Perspective Therapeutics Earnings
Data Unavailable
Perspective Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.